Nova Biomedical develops, manufactures and commercializes analytical systems for cell culture, chemistry and whole blood testing. The company is headquartered in Waltham, MA, USA and employs more than 1,500 people worldwide. Nova Biomedical has been a global leader in the development of biosensors for clinical analysis and cell culture/fermentation for over 40 years. In Germany, Nova Biomedical has full commercial team including a warehouse and distribution center as well as a local support team committed to customer excellence.
Nova's BioProfile® FLEX2 is the latest model in the BioProfile family of automated cell culture analyzers. FLEX2 combines sensor card technology with optical cell imaging technology and freezing point osmometry. FLEX2 is available with an optional on-line autosampler and optional CDV (cell density and viability) functionality. The on-line autosampler enables fully automated sampling and analysis for up to 10 bioreactors. FAST CDV delivers results in 70 seconds using 100uL of sample volume. All sample dilutions are performed internally, enabling cell culture samples up to 140e6 c/mL to be analyzed without any external sample dilution.
Further information: www.novabiomedical.com